report better-than-expect fiscal result strong revenu
million versu consensu expect million adjust
oper expans drive meaning out-performance adjust ep
versu consensu expect quarter compani
achiev constant currenc organ growth exceed
forecast driven strength healthcar product constant
currenc basi appli steril constant
year estim notabl adjust gross
margin quarter particularli strong bp year-over-year
aid price bp year-over-year product currenc
ste combin order backlog healthcar life scienc product
increas year-over-year million end fiscal
time healthcar capit shipment ste healthcar capit sale
increas roughli constant currenc basi fiscal versu
low-single-digit forecast aid fiscal result correspond
neg impact compani healthcar equip backlog
year-over-year million opposit dynam appear occur
ste life scienc capit busi capit sale declin low
double-digit rate year-over-year follow except strong fiscal
life scienc capit backlog increas year-over-year
follow better-than-anticip fiscal rais constant
currenc organ growth guidanc increment
acquisit account roughli half increas ste constant
currenc organ growth guidanc remaind upsid reflect
strength compani healthcar product appli steril
technolog divis addit compani increas adjust
ep outlook compani maintain
cash flow oper guidanc million
inclus roughli million increment one-tim cost associ
recent acquisit
rais adjust ep estim
new adjust ep forecast compani
total debt total asset
deliv strong result across four divis fiscal
compani appear well posit maintain elev organ growth behind
robust healthcar product launch activ capac addit competitor
struggl appli steril encourag custom
respons outsourc reprocess center initi reiter
buy rate increas price target
import pleas read disclosur disclaim page report
report fiscal adjust ep consensu expect estim
better-than-anticip revenu adjust gross margin contribut upsid rel adjust
ep forecast quarter
ste fiscal revenu increas year-over-year million consensu
expect million estim million quarter compani report constant
currenc organ growth exceed forecast driven better-than-expect result
healthcar product appli steril
plcfiscal adjust incom statement revenu analysisnorthcoast research thousand except percentag per share gross sg sg oper oper interest expens incom incom tax incom margin incom com share growth ep growth life appli steril healthcar specialti compani report northcoast research estim factset
growth posit fiscal forecast
quarter organ growth strong across healthcar product divis includ improv
roughli year-over-year healthcar consum driven steril assur instrument clean
chemistri v-pro consum year-over-year healthcar capit driven infect
prevent product notabl time healthcar capit shipment aid fiscal result
correspond neg impact compani healthcar equip backlog year-over-year
ri plcorgan growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research plchealthcar product organ growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research million overal believ demand healthcar equip remain favor note
discuss health order pipelin beyond order backlog recent earn call
fiscal ste life scienc busi post organ growth estim
expect compani life scienc capit sale weak low-double-digit organ reflect
time order life scienc capit growth last quarter year-over-year growth life
scienc consum servic compar last quarter
ste appli steril ast busi achiev constant currenc organ growth fiscal
forecast addit strong medic devic market demand ste ast
busi also benefit capac expans effort well modest market share gain relat
disrupt creat temporari perman closur sever competit ethylen oxid steril
facil moreov above-averag capit spend addit ast capac expans think organ
growth divis remain least high-single-digit rang intermediate-term
steri plcorder backlog analysi northcoast researchord backlog order scienc order scienc compani report northcoast research estim steri plclife scienc divis organ growth analysi compani report northcoast research
ste healthcar specialti servic busi achiev constant currenc organ growth fiscal
forecast heard ste north american instrument repair busi
exceed compani expect would guess high-single-digit rang believ legaci
synergi busi remain soft notabl ste outsourc reprocess center busi appear
remain track would guess revenu increas approxim million roughli
million moreov outsourc reprocess center busi continu ramp think
good visibl ste overal healthcar specialti servic divis least grow high-single-digit rate
ste fiscal adjust oper margin increas bp year-over-year
estim notabl adjust gross margin quarter particularli strong bp year-over-year
aid price bp year-over-year product currenc movement divis
standpoint ast healthcar product drove year-over-year increas ste fiscal adjust oper
complet sever small tuck-in acquisit fiscal addit microsystem acquisit last
quarter acquisit primarili aid healthcar product divis expect add
million revenu compani prior expect million acquisit revenu
microsystem deal alon
follow better-than-anticip fiscal rais constant currenc organ growth guidanc
increment acquisit account roughli half increas ste constant
currenc organ growth guidanc remaind upsid reflect strength compani healthcar
product appli steril divis addit compani increas adjust ep
outlook compani maintain cash flow oper
guidanc million inclus roughli million increment one-tim cost associ
recent acquisit
rais adjust ep estim new adjust ep forecast
compani
overal deliv strong result across four divis fiscal compani appear well
posit maintain elev organ growth behind robust healthcar product launch activ capac
addit competitor struggl appli steril encourag custom respons
 outsourc reprocess center initi reiter buy rate increas price
target
plcadjust oper margin healthcar life appli steril healthcar specialti fiscal exclud corpor expensesourc compani report northcoast research
steri plcannual incom statement analysi adjust northcoast research thousand except percent per share gross gross sg sg oper oper net interest expens incom incom incom tax minor net incom extra net margin extra extra net incom continu net wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim result adjust reflect adopt disclosur
